Chengdu JinRui Foundation Biotechnology

Chengdu JinRui Foundation Biotechnology is a biopharmaceutical company based in Chengdu, China, specializing in the research, development, and production of innovative therapeutic proteins and small molecule drugs. The company's flagship product is Jin Li Tai (teriparatide), a recombinant human parathyroid hormone used for the treatment of postmenopausal osteoporosis. Beyond its commercial success in bone metabolism, JinRui Foundation is advancing a pipeline of long-acting biologics and targeted oncology treatments. The firm operates a comprehensive R&D center and a GMP-certified manufacturing facility to support its full-cycle drug development strategy. Its research focus extends to endocrine disorders and various forms of cancer, leveraging proprietary expression and purification platforms. The company is recognized as a high-tech enterprise within the Chengdu High-tech Zone and maintains collaborations with several domestic research institutions.